Literature DB >> 15698384

Management of skin reactions during radiotherapy: a study of nursing practice.

S D'haese1, T Bate, S Claes, A Boone, V Vanvoorden, F Efficace.   

Abstract

The aim of this study was to investigate the consensus of skin care advice given by nurses during radiotherapy. Sixty-seven nurses, identified through nine Belgian radiotherapy departments, responded to a questionnaire survey consisting of 58 items regarding prevention and management of erythema, dry desquamation and moist desquamation. Consensus for a given advice was categorized as small if less than 50% of the nurses gave the same answer, as moderate if between 50% and 75% and as large when more than 75%. Overall, 33% of the items showed small consensus, 29% showed moderate consensus and 38% showed large consensus. The highest consensus was seen for advice in cases of moist and dry desquamation. There was less agreement in the case of erythema and it decreased further for preventive advice. Some skin care techniques that were frequently used by the nurses cannot be supported by the literature. Also, some techniques recommended by the literature are not frequently used. Further, few differences (P < 0.05) between nurses working in a university hospital and the ones working in a non-university hospital were found in terms of advice given to patients. To increase consensus on skin care issues more conclusive research is needed. Of equal importance is the translation of existing research results into daily clinical practice.

Entities:  

Mesh:

Year:  2005        PMID: 15698384     DOI: 10.1111/j.1365-2354.2005.00510.x

Source DB:  PubMed          Journal:  Eur J Cancer Care (Engl)        ISSN: 0961-5423            Impact factor:   2.520


  8 in total

1.  Mepilex Lite dressings for the management of radiation-induced erythema: a systematic inpatient controlled clinical trial.

Authors:  K V Diggelmann; A E Zytkovicz; J M Tuaine; N C Bennett; L E Kelly; P M Herst
Journal:  Br J Radiol       Date:  2010-07-20       Impact factor: 3.039

Review 2.  Acute effects of radiation treatment: skin reactions.

Authors:  Erica B Collen; Monique N Mayer
Journal:  Can Vet J       Date:  2006-09       Impact factor: 1.008

3.  Prophylaxis and management of acute radiation-induced skin reactions: a systematic review of the literature.

Authors:  N Salvo; E Barnes; J van Draanen; E Stacey; G Mitera; D Breen; A Giotis; G Czarnota; J Pang; C De Angelis
Journal:  Curr Oncol       Date:  2010-08       Impact factor: 3.677

Review 4.  Topical agent therapy for prevention and treatment of radiodermatitis: a meta-analysis.

Authors:  Yuejiao Zhang; Shoude Zhang; Xiaoling Shao
Journal:  Support Care Cancer       Date:  2012-10-12       Impact factor: 3.603

5.  Mepilex Lite dressings for managing acute radiation dermatitis in nasopharyngeal carcinoma patients: a systematic controlled clinical trial.

Authors:  Wen-Huan Zhong; Qiong-Fen Tang; Lian-Ying Hu; Hui-Xia Feng
Journal:  Med Oncol       Date:  2013-11-02       Impact factor: 3.064

6.  Comparison of the Effect of Alpha and Hydrocortisone Ointments on Prevention of Acute Skin Complications Due to Radiotherapy in Breast Cancer Patients.

Authors:  Mansour Rezaei; Ahmad Khoshay; Nasrin Amirifard; Ali Goli; Alireza Abdi
Journal:  J Skin Cancer       Date:  2021-06-16

7.  Efficacy of topical alpha ointment (containing natural henna) compared to topical hydrocortisone (1%) in the healing of radiation-induced dermatitis in patients with breast cancer: a randomized controlled clinical trial.

Authors:  Mansour Ansari; Dehsara Farzin; Ahmad Mosalaei; Shapour Omidvari; Niloofar Ahmadloo; Mohammad Mohammadianpanah
Journal:  Iran J Med Sci       Date:  2013-12

8.  Prophylactic Treatment with Adlay Bran Extract Reduces the Risk of Severe Acute Radiation Dermatitis: A Prospective, Randomized, Double-Blind Study.

Authors:  Chih-Jen Huang; Ming-Feng Hou; Jung-Yu Kan; Chiung-Hui Juan; Shyng-Shiou F Yuan; Kuei-Hau Luo; Hung-Yi Chuang; Stephen Chu-Sung Hu
Journal:  Evid Based Complement Alternat Med       Date:  2015-10-01       Impact factor: 2.629

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.